Boston CEO
Tue, May 30, 2017
Four Seasons Boston
200 Boylston Street
Boston, MA 02116
(617) 338-4400
Cost: $1950 per person
Dress Code: Business Attire
Boston CEO is a networking forum for industry CEOs and decision makers in the life sciences. Attendees gain insights from presentations and panels featuring CEOs from several of the world's leading biopharmaceutical companies. Industry leaders in venture capital and private equity also participate.
Speakers and co-hosts include: Paul Biondi, SVP, Head, BD, Bristol-Myers Squibb; Ron Cooper, President & CEO, Albireo Pharma; Robert Coughlin, President & CEO, Mass Bio; Deborah Dunsire, CEO, XTuit Pharmaceuticals; Michael Ehlers, EVP, R&D, Biogen; JC Gutierrez-Ramos, CEO, Synlogic Therapeutics; John Haurum, CEO, F-star Biotechnology; Mary Lynne Hedley, Co-Founder, President & COO, TESARO; William Heiden, CEO, AMAG Pharmaceuticals; Ed Kaye, CEO, Sarepta Therapeutics; Jonathan Lewis, CEO, Samus Therapeutics; Martin Mackay, EVP, Head, R&D, Alexion; John Maraganore, CEO, Alnylam; Geoffrey McDonough, President & CEO, Swedish Orphan Biovitrum; David Meek, CEO, IPSEN; Kia Motesharei, VP, Global Head of BD, Neurology & Immunology, EMD Serono; Francois Nader, Chairman, Acceleron Pharma; Paris Panayiotopoulos, former President & CEO, ARIAD; Adelene Perkins, Chairman & CEO, Infinity Pharmaceuticals; Steven Perrin, CEO & CSO, ALSTDI; Roger Pomerantz, President, CEO & Chairman, Seres Therapeutics; Chandra Ramanathan, VP & Head, East Cost Innovation Center, Bayer; Al Sandrock, CMO & EVP, Neurology Discovery & Development, Biogen; Bob Silverman, Head Externalized Drug Discovery Partnering, Roche; Paula Soteropoulos, CEO, Akcea Therapeutics; Roger Tung, CEO, Concert Pharmaceuticals; Sue Washer, President & CEO, AGTC; Christoph Westphal, Co-Founder & Partner, Longwood Fund
"Boston CEO is the elite meeting for leaders in biotech. This top notch meeting features unrivaled networking and candid discussions on the most pressing topics facing the industry.” - Henri Termeer, former CEO, Genzyme
"The Boston CEO conference is an invaluable opportunity for CEOs to gather in a casual and off-the-record atmosphere and discuss the most pressing issue in the biotech space and beyond. I look forward to these conferences and fully support their mission to continue to grow Boston’s thriving biopharma community.” — John Maraganore, CEO, Alnylam
Please call reservations at the Four Seasons today to book your accommodations. Telephone: (617) 338-4400. Please mention the Boston Biotech Conference rate.
Boston CEO - May 30, 2017 - Four Seasons
Co-hosts: Nessan Bermingham, Paul Biondi, Suzanne Bruhn, Ron Cooper, Robert Coughlin, Deborah Dunsire, Michael Ehlers, Chris Garabedian, JC Gutierrez-Ramos, Mary Lynne Hedley, William Heiden, Ed Kaye, Jay Luly, Martin Mackay, Sandy Macrae, John Maraganore, Geoffrey McDonough, David Meek, Paris Panayiotopoulos, Adelene Perkins, Rob Perez, Roger Pomerantz, Ronald Renaud, Al Sandrock, Paula Soteropoulos, Roger Tung, Sue Washer, Christoph Westphal
| Time |
Agenda |
|---|
| 7:30-8:30 am |
Registration and Networking Breakfast
|
| 8:30-9:00 am |
Welcoming Remarks -- Remembering a Biotech Legend: Henri Termeer
Christoph Westphal, Co-Founder & Partner, Longwood Fund; Rob Perez, Founder & Chairman, Life Science Cares; Deborah Dunsire, CEO, XTuit Pharmaceuticals; Geoffrey McDonough, President & CEO, Swedish Orphan Biovitrum; Richard Moscicki, Deputy Director, Science Operations, CDER, FDA
|
| 9:00-9:20 am |
Moderated Keynote
Richard Moscicki, Deputy Director, Science Operations, CDER, FDA
Moderator: Christoph Westphal, Co-Founder & Partner, Longwood Fund
|
| 9:20-9:50 am |
CEO Roundtable
Deborah Dunsire, CEO, XTuit Pharmaceuticals; Geoffrey McDonough, President & CEO, Swedish Orphan Biovitrum; Kabir Nath, President & CEO North America Pharmaceuticals, Otsuka America; Rob Perez, Founder & Chairman, Life Science Cares
Moderator: Pierre Jacquet, Managing Director, L.E.K. Consulting
|
| 9:50-10:20 am |
Healthcare Market Outlook -- 2017 and Beyond
Robert Guidos, Associate Director, Legislative Affairs, CDER, FDA; Jeff Leerink, Chairman & CEO, Leerink Partners; Jessica Richman, CEO, uBiome; Thilo Schroeder, Partner, Nextech Invest; Gary Zieziula, President & Managing Director, EMD Serono
Moderator: Michael Goettler, Global President, Rare Diseases, Pfizer
|
| 10:20-10:50 am |
Networking Break
|
| 10:50-11:20 am |
Understanding and Managing Growth
Mary Lynne Hedley, Co-Founder, President & COO, TESARO; William Heiden, CEO, AMAG Pharmaceuticals; Sanjiv Patel, CEO, Relay Therapeutics; Shalini Sharp, CFO, Ultragenyx; Timothy Wright, EVP, Strategy, BD, & Innovation, Teva
Moderator: Robert Beardsley, COO, Galera Therapeutics
|
| 11:20-11:50 am |
Diversity: Moving from Sound Bite to Implementation
Jeff Albers, CEO, Blueprint Medicines; Suzanne Bruhn, President & CEO, Proclara Biosciences; Amri Johnson, Global Head, Diversity & Inclusion, Novartis Institutes for BioMedical Research; Helen Torley, President & CEO, Halozyme Therapeutics
Moderator: Cissy Young, Executive Director, Russell Reynolds
|
| 11:50-12:20 pm |
Ensuring Transparency and Drug Value
Melissa Bradford-Klug, CBO, Keryx; Thomas Lönngren, former Executive Director, European Medicines Agency; Ed Mascioli, CEO, Karos Pharmaceuticals; Gilmore O'Neill, SVP, Late Stage Clinical Development, Biogen
Moderator: Ron Cooper, President & CEO, Albireo
|
| 12:20-1:20 pm |
Networking Lunch
|
| 1:20-1:50 pm |
Accessing Early-Stage Innovation
Ansbert Gadicke, Co-Founder & Managing Director, MPM Capital; Arthur Krieg, CEO & Founder, Checkmate Pharmaceuticals; Brian McVeigh, VP, WWBD Transactions & Investment Management, GlaxoSmithKline; Chandra Ramanathan, Head, East Coast Innovation Center, Bayer; Ken Rhodes, CSO, Yumanity
Moderator: Adi Hoess, CEO, Affimed
|
| 1:50-2:20 pm |
Therapeutic Market Focus: Microbiome
Rodolphe Clerval, CBO, Enterome; Bernat Olle, CEO, Vedanta Biosciences; Jeff Riley, CEO, Synthetic Biologics; Michele Trucksis, CMO, Seres Therapeutics
Moderator: Todd Krueger, President, AOBiome
|
| 2:20-2:50 pm |
Oncology Trends and Predictions
Gil Beyen, Chairman & CEO, Erytech; Roman Fleck, CEO, Janpix; Jimmy Lin, CSO, Natera; Oliver Rosen, CMO, Deciphera; Patrick Tricoli, CEO, Nanobiotix US
Moderator: Jeremy Goldberg, Managing Director, Torreya Partners
|
| 2:50-3:20 pm |
Networking Break
|
| 3:20-3:50 pm |
Building a Biotech: Innovative Business Models
JC Gutierrez-Ramos, CEO, Synlogic Therapeutics; Ana Maiques, CEO, Neuroelectrics; Eddie Martucci, Co-Founder & CEO, Akili Interactive; Paula Soteropoulos, CEO, Akcea Therapeutics; Gregory Verdine, Founder, CEO, & CSO, FogPharma
Moderator: Yuval Cohen, CEO, Corbus Pharmaceuticals
|
| 3:50-4:20 pm |
Partner or Go it Alone?
Sharon Clarke, CBO, JDP Therapeutics; Kia Motesharei, Global Head, BD, Neurology & Immunology, EMD Serono; Tim Noyes, President & CEO, Proteon Therapeutics; Mark Nuttall, Head, MS & Immunology BD&L, Sanofi Genzyme
Moderator: Chris Casey, Global Head, Key Accounts & Services, Commercial, inVentiv Health
|
| 4:20-4:50 pm |
Next Generation Biotech CEOs and Board Members
Nessan Bermingham, President & CEO, Intellia Therapeutics; Nancy Lurker, President & CEO, pSivida; Francois Nader, Chairman, Acceleron Pharma; Matt Roden, VP, Strategic Corporate Development, Bristol-Myers Squibb; Leslie Williams, Founder, President & CEO, ImmusanT
Moderator: Robert Forrester, President & CEO, Verastem
|
| 4:50-6:00 pm |
Cocktails and Hors d'oeuvres
|
May 31, 2017
Co-hosts: Nessan Bermingham, Paul Biondi, Suzanne Bruhn, Ron Cooper, Robert Coughlin, Deborah Dunsire, Michael Ehlers, Chris Garabedian, JC Gutierrez-Ramos, Mary Lynne Hedley, William Heiden, Ed Kaye, Jay Luly, Martin Mackay, Sandy Macrae, John Maraganore, Geoffrey McDonough, David Meek, Paris Panayiotopoulos, Adelene Perkins, Rob Perez, Roger Pomerantz, Ronald Renaud, Al Sandrock, Paula Soteropoulos, Roger Tung, Sue Washer, Christoph Westphal
| Time |
Agenda |
|---|
| 7:30-8:30 am |
Registration and Networking Breakfast
|
| 8:30-8:40 am |
Welcome and Opening Remarks
Roger Tung, CEO, Concert Pharmaceuticals; Sue Washer, President & CEO, AGTC; Steve Cutler, CEO, ICON; Al Sandrock, CMO & EVP, Biogen
|
| 8:40-9:10 am |
Advances in Personalized Medicine
Arthur Hiller, CEO, Antyllus; Kenneth Moch, President & CEO, Cognition Therapeutics; Joe Payne, President & CEO, Arcturus; Steven Perrin, CEO & CSO, ALS Therapy Development Institute; Al Sandrock, CMO & EVP, Biogen
Moderator: Robert Silverman, Head, Externalized Drug Discovery Partnering, Roche
|
| 9:10-9:40 am |
Small-Cap and Private Biotech: Leveraging Potential
Frederick Beddingfield, President & CEO, Sienna Biopharmaceuticals; Alan Ezekowitz, CEO, Abide Therapeutics; Brian Leuthner, President & CEO, Edge Therapeutics; Dan Swisher, CEO, Sunesis Pharmaceuticals; Ailis Tweed-Kent, Founder & CEO, Cocoon Biotech
Moderator: Gregg Beloff, CFO, Centrexion Therapeutics
|
| 9:40-10:10 am |
Therapeutic Market Focus: Cell & Gene Therapy
Al Gianchetti, CEO, XyloCor Therapeutics; Michael Jirousek, COO, Frequency Therapeutics; Jak Knowles, President & CEO, Exonics Therapeutics; Sam Rasty, COO, Homology Medicines; Amber Salzman, President & CEO, Adverum Biotechnologies
Moderator: Pascal Touchon, SVP, Global Head Strategy & BD&L, Novartis
|
| 10:10-10:40 am |
Networking Break
|
| 10:40-11:00 am |
Fireside Chat
Michael Ehlers, EVP, R&D, Biogen; David Meek, CEO, IPSEN
Moderator: Christoph Westphal, Co-Founder & Partner, Longwood Fund
|
| 11:00-11:30 am |
Accessing Innovation via M&A and Partnerships
Sven Dethlefs, Global Head Respiratory Medicines, Teva; Elcin Ergun Barker, President, New Business, EMD Serono; Jeff Jonker, President, NGM Bio; Cynthia Schwalm, President, North America Commercial Operations, IPSEN; Malcolm Weir, CEO, Heptares
Moderator: Sue Washer, President & CEO, AGTC
|
| 11:30-12:00 pm |
Buy or Build?
Danguole Altman, President & CEO, Vapogenix; Grace Colon, CEO, InCarda Therapeutics; John Cox, CEO, Bioverativ; Roger Tung, CEO, Concert Pharmaceuticals
Moderator: Steve Cutler, CEO, ICON
|
| 12:00-1:00 pm |
Networking Lunch
|
| 1:00-1:30 pm |
Evolving BioPharma Boards
James Geraghty, Chairman, Juniper Pharma; Quang Pham, Founder, Chairman & CEO, Espero Pharmaceuticals; Ronald Renaud, CEO, RaNA Therapeutics; David Southwell, President & CEO, Inotek Pharmaceuticals
Moderator: Don deBethizy, Chairman, Albumedix A/S
|
| 1:30-2:00 pm |
Boston-Bound Biotech and Pharma: Impact on Innovation
Paul Biondi, SVP, Head, BD, Bristol-Myers Squibb; Paul Bolno, President & CEO, WAVE Life Sciences; Chris Garabedian, Chairman & CEO, Xontogeny; Ole Isacson, Founder, NyaCell; Jonathan Lewis, CEO, Samus Therapeutics
Moderator: Robert Coughlin, President & CEO, MassBio
|
| 2:00-2:30 pm |
Global Markets: Biotechs Across Borders
Carolina Alarco, President, Global Marketing & International Markets, Aegerion; Samantha Du, Chairperson & CEO, Zai Laboratory; Mark Rothera, CCO, PTC Therapeutics; James Xue, CEO, CANbridge Life Sciences
Moderator: Mary Szela, CEO, Novelion Therapeutics
|
| 2:30-3:00 pm |
Networking Break
|
| 3:00-3:20 pm |
Fireside Chat
Robert Coughlin, President & CEO, MassBio; John Maraganore, CEO, Alnylam
Moderator: Christoph Westphal, Co-Founder & Partner, Longwood Fund
|
| 3:20-3:50 pm |
Achieving Organizational Turnarounds
Richard Daly, Chairman & CEO, Neuralstem; Ed Kaye, CEO, Sarepta; Sandy Macrae, CEO, Sangamo Therapeutics; Adelene Perkins, Chairman & CEO, Infinity Pharmaceuticals
Moderator: Hugh Cole, CBO, ARIAD
|
| 3:50-4:20 pm |
M&A Activity Post the IPO-Boom: Impact on Fundraising and Dealmaking
Luc Dochez, CEO, Tusk Therapeutics; Luba Greenwood, VP, Global BD & M&A, Roche; John Haurum, CEO, F-star Biotechnology; Jim Healy, Managing General Partner, Sofinnova Ventures
Moderator: Philippe Lopes-Fernandes, SVP, Global Head, BD & Alliance Management, EMD Serono
|
| 4:20-4:30 pm |
Presentation of 2017 Boston CEO Lifetime Achievement Award
Robert Coughlin, 2016 Honoree; John Maraganore, 2015 Honoree
|
| 4:30-5:30 pm |
Cocktails and Hors d'oeuvres
|
Hotels
| Name |
Address |
Phone |
|---|
| Four Seasons Boston |
200 Boylston St, Boston, MA |
(617) 338-4400 |